Atorvastatin Calcium
Product Images NDC 68071-5231

5 FDA label images from Nucare Pharmaceuticals,inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-5231). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Pdp (68071 5231 9)

Pdp (68071 5231 9)
Label for Atorvastatin Calcium 40mg tablets from NuCare Pharmaceuticals, Inc., with NDC 68071-5231. The bottle contains 90 tablets. The label includes manufacturer details, barcode, lot number, expiration, and storage instructions to keep at 59-86°F and out of reach of children. The product is prescription only.*
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A line graph showing cumulative incidence percentage over time in years for Atorvastatin and Placebo groups. The graph compares incidence rates, with Atorvastatin represented by a solid line indicating lower incidence than the dashed line for Placebo. The hazard ratio (HR) and p-value are noted at the bottom of the graph.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A line graph comparing the cumulative hazard percentage over time between Atorvastatin and Placebo groups. The x-axis represents time in years up to 5 years, and the y-axis shows cumulative hazard percentage. Atorvastatin shows a lower cumulative hazard than Placebo throughout the study period, with statistical data indicating HR 0.63 (0.48-0.83), p=0.001.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A line chart comparing the percentage of subjects experiencing a major cardiovascular event over a 5-year period for Atorvastatin 10 mg and 80 mg dosages. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis represents the percentage of subjects. A hazard ratio (HR 0.78) with confidence interval and p-value is also shown on the graph.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of atorvastatin calcium, showing the molecular arrangement including calcium ions, as submitted by NuCare Pharmaceuticals, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.